These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3264166)

  • 1. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefoxitin compared with the activity of other antibiotics and trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    Med Klin; 1978 Mar; 73(12):423-7. PubMed ID: 347234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of norfloxacin and other chemotherapeutic agents on the adhesion of bacteria of the uro-vaginal tract to uroepithelial cells].
    Carlone NA; Borsotto M; Cuffini AM; Savoia D
    G Batteriol Virol Immunol; 1985; 78(7-12):185-204. PubMed ID: 3879893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the antibacterial activity of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
    Legler F
    Arzneimittelforschung; 1976; 26(42):658-61. PubMed ID: 947327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of Acalypha indica L.
    Govindarajan M; Jebanesan A; Reetha D; Amsath R; Pushpanathan T; Samidurai K
    Eur Rev Med Pharmacol Sci; 2008; 12(5):299-302. PubMed ID: 19024213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2014 Apr; 69(4):1050-6. PubMed ID: 24257317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of imipenem against 1386 clinical isolates.
    Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro brodimoprim activity on bacterial strains.
    Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
    J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the susceptibilities of anaerobic bacteria to trimethoprim and sulfamethoxazole individually and in combination.
    Tosolini FA; Butcher RH
    Clin Ther; 1983; 5(6):629-31. PubMed ID: 6605193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.
    Qadri SM; Lee G; Brodie L
    Drugs Exp Clin Res; 1989; 15(8):349-53. PubMed ID: 2598776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.